Ms. Mitchell has experience in the design, management, and statistical analysis of prospective and retrospective epidemiologic studies. Ms. Mitchell also has extensive experience in writing structured literature reviews and critical reviews of scientific literature. Since joining Exponent, she has provided epidemiologic evaluations and support for numerous cancer types and research areas, including electric and magnetic fields, benzene, butadiene, ethylene oxide and asbestos. She has also provided support to pharmaceutical companies in understanding the burden of particular cancers and events worldwide. She has gained significant experience communicating health risk to the public and testifying in hearings.
Prior to joining Exponent, Ms. Mitchell worked as a consultant in the field of health outcomes, health economics, and pharmacoepidemiology. She has experience in design of large-scale database analysis projects, SAS programming, the statistical interpretation of study results, and the preparation of budget impact models. Ms. Mitchell also served as a project manager for a cohort study examining the dynamics of infectious disease transmission. As part of this work, Ms. Mitchell assisted in the development of an HIV surveillance system in Brooklyn, NY.
Mitchell ME, Mehta J, Lau E, Fryzek J. National-level descriptive epidemiology of Pediatric Acute Lymphoblastic Leukemia (pALL). Presented at the American Society for Pediatric Hematology Oncology, April 2011.
Yong M, Kuehn C, Kelsh M, Wagner M, Yang A, Franklin J. Associations between platelet count and survival and disease progression in thrombocytopenic patients with myelodysplastic syndromes. Presented at the American Society of Hematology, 2010.
Alexander DD, Wagner ME. Benzene exposure and non-Hodgkin lymphoma: a meta-analysis of epidemiologic studies. J Occup Environ Med 2010; 52(2):169–89.
Teta MJ, Wagner ME. Consistency and synergy. Blood 2009; 114(9):2000-1; author reply 2001.
Erdreich LS, Alexander DD, Wagner ME, Reinemann D. Meta-analysis of stray voltage on dairy cattle. J Dairy Sci 2009; 92(12):5951–5963.
Wagner ME, Travis LB. Letter to the editor re: “Mesothelioma and asbestos.” Regul Toxicol Pharmacol 2008; 52(3):353–354; author reply 355.
Bailey WH, Wagner ME. IARC evaluation of ELF magnetic fields: Public understanding of the 0.4-lT exposure metric. J Exposure Sci Environ Epidemiol 2008; 18:233–235.
Miller M, Liao Y, Wagner M, Korves C. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sexually Transmitted Diseases, December 2007; 35(12).
Teta MJ, Lau E, Sceurman BK, Wagner ME. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer 2007 Apr 1; 109(7):1432–1438.
Kaetzel R, Wagner M, Sweeney L, Duggan A, Gargas M, Teta MJ. An evaluation of early-life susceptibility and exposures to ethylene oxide. Society of Toxicology Conference, Charlotte, NC, March 25–29, 2007.
Hardick J, Gaydos CA, Wagner M, Hardick A, Wood BJ, Miller M. High prevalence of
Trichomonas vaginalis among women who use drugs in New York City. National STD Prevention Conference, Philadelphia, PA, March 8–11, 2004.